Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-056333
Filing Date
2025-12-10
Accepted
2025-12-10 16:37:26
Documents
1
Period of Report
2025-12-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1765402643.html 4  
1 FORM 4 wk-form4_1765402643.xml 4 3992
  Complete submission text file 0001628280-25-056333.txt   5498
Mailing Address 300 FIFTH AVENUE WALTHAM MA 02451
Business Address 300 FIFTH AVENUE WALTHAM MA 02451 617-430-5595
CRESCENT BIOPHARMA, INC. (Issuer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O DYNE THERAPEUTICS, INC. 830 WINTER STREET WALTHAM MA 02451
Business Address
McNeill Jonathan (Reporting) CIK: 0001824673 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36177 | Film No.: 251562445